Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Stomatitis 9Neoplasms 6Head and Neck Neoplasms 4Multiple Myeloma 2Mucositis 2Leukemia 2Xerostomia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Oral Ulcer 1Lymphoma, Non-Hodgkin 1Lymphoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Laryngeal Diseases 1Hematologic Neoplasms 1Graft vs Host Disease 1Deglutition Disorders 1Colonic Neoplasms 1Cataract 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 367Pemetrexed 308pembrolizumab 302Cisplatin 242Paclitaxel 230Docetaxel 199Gemcitabine 130Nivolumab 121Erlotinib Hydrochloride 114Bevacizumab 85osimertinib 78atezolizumab 65durvalumab 58Cetuximab 57130-nm albumin-bound paclitaxel 56Gefitinib 52Ipilimumab 46Afatinib 38Drug Therapy 33Cyclophosphamide 30Crizotinib 30Albumin-Bound Paclitaxel 30Vinorelbine 28cemiplimab 26tislelizumab 25avelumab 23icotinib 22Radiotherapy 22capmatinib 21Oxaliplatin 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Carcinoma, Non-Small-Cell Lung × Fibroblast Growth Factor 7 × Clear all
NCT00094861 2017-03-14

Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Swedish Orphan Biovitrum

Phase 2 Completed
100 enrolled 19 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Deglutition Disorders, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡